Cited by 275

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Rab38 and Rab32 control post-Golgi trafficking of melanogenic enzymes

Wasmeier, Christina, Romao, Maryse, Plowright, Lynn, Bennett, Dorothy C., Raposo, Graça, Seabra, Miguel C.·2006·The Journal of Cell Biology

Abstract

Amutation in the small GTPase Rab38 gives rise to the mouse coat color phenotype “chocolate” (cht), implicating Rab38 in the regulation of melanogenesis. However, its role remains poorly characterized. We report that cht Rab38G19V is inactive and that the nearly normal pigmentation in cht melanocytes results from functional compensation by the closely related Rab32. In cht cells treated with Rab32-specific small interfering RNA, a dramatic loss of pigmentation is observed. In addition to mature melanosomes, Rab38 and Rab32 localize to perinuclear vesicles carrying tyrosinase and tyrosinase-related protein 1, consistent with a role in the intracellular sorting of these proteins. In Rab38/Rab32-deficient cells, tyrosinase appears to be mistargeted and degraded after exit from the trans-Golgi network (TGN). This suggests that Rab38 and Rab32 regulate a critical step in the trafficking of melanogenic enzymes, in particular, tyrosinase, from the TGN to melanosomes. This work identifies a key role for the Rab38/Rab32 subfamily of Rab proteins in the biogenesis of melanosomes and potentially other lysosome-related organelles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1083/jcb.200606050

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The phenotypes of rab32a and hps5 mutants suggest distinct contributions to crystal morphology and organelle maturation.

    “Notably, the phenotypes of rab32a and hps5 mutants suggest distinct contributions also to crystal morphology and organelle maturation, mirroring the specialized trafficking roles previously ascribed to these proteins in melanosomes (30, 41, 85, 90, 91).”

    From Lysosome-related organelles orchestrate guanine crystal formation in pigment cells (2026) · cites this paper as [41]

    The Results and Discussion describe Rab32/Rab38-dependent trafficking of melanogenic enzymes and a loss of mature, but not stage II, melanosomes in deficient cells. The Discussion also notes that different HPS mutants disrupt melanosome maturation at different stages. It does not examine rab32a or hps5 mutants, compare their phenotypes, or address crystal morphology; those specifics are not supported by this source. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The partial reduction in crystal formation in rab32a and ap3m2 mutants is consistent with known redundancy and compensatory trafficking pathways in LRO biology.

    “The phenotypes we observed for rab32a and ap3m2 mutants show partial yet statistically significant reduction in crystal formation, a feature that is consistent with known redundancy and compensatory trafficking pathways in LRO biology (41, 48, 89).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. 2002, Eur. J. Biochem., 269, 259, 10.1046/j.0014-2956.2001.02645.x · DOI
  2. 2003, Pigment Cell Res., 16, 333, 10.1034/j.1600-0749.2003.00067.x · DOI
  3. 2003, Biochim. Biophys. Acta., 1651, 68, 10.1016/S1570-9639(03)00236-X · DOI
  4. 2002, Hum. Gene Ther., 13, 803, 10.1089/10430340252898984 · DOI
  5. 2002, Zoolog. Sci., 19, 981, 10.2108/zsj.19.981 · DOI
  6. 2004, Blood., 104, 3181
  7. 2005, J. Dermatol. Sci., 37, 3, 10.1016/j.jdermsci.2004.08.014 · DOI
  8. 2005, Mol. Biol. Cell., 16, 3273, 10.1091/mbc.e05-01-0060 · DOI
  9. 2001, Mol. Biol. Cell., 12, 2075, 10.1091/mbc.12.7.2075 · DOI
  10. 2001, J. Cell Biol., 152, 795, 10.1083/jcb.152.4.795 · DOI
  11. 2002, Traffic., 3, 193, 10.1034/j.1600-0854.2002.030305.x · DOI
  12. 2000, Cancer Res., 60, 3584
  13. 2001, Biochem. J., 355, 681, 10.1042/bj3550681 · DOI
  14. 2004, Bioessays., 26, 616, 10.1002/bies.20042 · DOI
  15. 2002, Proc. Natl. Acad. Sci. USA., 99, 4471, 10.1073/pnas.072087599 · DOI
  16. 2004, Proc. Natl. Acad. Sci. USA., 101, 11652, 10.1073/pnas.0401926101 · DOI
  17. 2001, Nat. Rev. Mol. Cell Biol., 2, 738, 10.1038/35096009 · DOI
  18. 2002, Curr. Opin. Cell Biol., 14, 506, 10.1016/S0955-0674(02)00350-2 · DOI
  19. 2004, J. Invest. Dermatol., 122, 452, 10.1046/j.0022-202X.2004.22117.x · DOI
  20. 2002, J. Invest. Dermatol., 119, 1156, 10.1046/j.1523-1747.2002.19535.x · DOI
  21. 1999, Nat. Cell Biol., 1, 376, 10.1038/14075 · DOI
  22. 2001, Am. J. Pathol., 158, 1665, 10.1016/S0002-9440(10)64122-3 · DOI
  23. 1996, J. Cell Biol., 135, 153, 10.1083/jcb.135.1.153 · DOI
  24. 2001, J. Mol. Biol., 313, 889, 10.1006/jmbi.2001.5072 · DOI
  25. 2001, Trends Cell Biol., 11, 487, 10.1016/S0962-8924(01)02147-X · DOI
  26. 2005, Traffic., 6, 525, 10.1111/j.1600-0854.2005.00299.x · DOI
  27. 2005, J. Invest. Dermatol., 124, 420, 10.1111/j.0022-202X.2004.23585.x · DOI
  28. 2004, Traffic., 5, 393, 10.1111/j.1398-9219.2004.00190.x · DOI
  29. 2004, Curr. Opin. Cell Biol., 16, 451, 10.1016/j.ceb.2004.06.014 · DOI
  30. 1995, J. Biol. Chem., 270, 24420, 10.1074/jbc.270.41.24420 · DOI · Paper page
  31. 2001, Curr. Opin. Cell Biol., 13, 500, 10.1016/S0955-0674(00)00242-8 · DOI
  32. 2004, Science., 305, 55, 10.1126/science.1095291 · DOI
  33. 2003, J. Dermatol. Sci., 32, 131, 10.1016/S0923-1811(03)00071-9 · DOI
  34. 2002, J. Natl. Cancer Inst., 94, 446, 10.1093/jnci/94.6.446 · DOI
  35. 2005, Mol. Biol. Cell., 16, 5356, 10.1091/mbc.e05-07-0626 · DOI · Paper page
  36. 2005, Pigment Cell Res., 18, 322, 10.1111/j.1600-0749.2005.00269.x · DOI · Paper page
  37. 2006, J. Cell Sci., 119, 1080, 10.1242/jcs.02804 · DOI
  38. 2004, Blood., 104, 2714
  39. 2004, J. Biol. Chem., 279, 7971, 10.1074/jbc.M309714200 · DOI
  40. 2006, Pigment Cell Res., 19, 19, 10.1111/j.1600-0749.2005.00289.x · DOI
  41. 2001, Nat. Rev. Mol. Cell Biol., 2, 107, 10.1038/35052055 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Wasmeier, C., Romao, M., Plowright, L., Bennett, D. C., Raposo, G., & Seabra, M. C.
Affiliations
  • 1Molecular and Cellular Medicine, Division of Biomedical Sciences, Imperial College London, London SW7 2AZ, England, UK
  • 2Institut Curie, Centre National de la Recherche Scientifique, UMR144, Paris, Cedex 75005, France
  • 3Department of Basic Medical Sciences, St George's University of London, London SW17 0RE, England, UK
Venue
The Journal of Cell Biology
Published
2006-10-16
Volume
175
Issue
2
Pages
271-281
ISSN
  • 1540-8140
  • 0021-9525
Cited by
275
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review